Table1.
Characteristics of the sample dichotomized by NYHA functional class
| Total | NYHA = I /II | NYHA = III/IV | p * | ||
|---|---|---|---|---|---|
| Number of patients | 99 (100%) | 59 (59.60%) | 40 (40.40%) | 0.0699 | |
| Age | |||||
| Average ± SD | 61.05 ± 10.88 | 59.85 ± 10.65 | 62.83 ± 11.11 | 0.1829 | |
| Monthly family income | |||||
| Median (1st Qu.; 3rd Qu.) | 914.28 (594.61; 1294.61) | 892.3 (594.61; 1564.10) | 923.07 (602.56; 1102.56) | 0.3978 | |
| Ejection Fraction | |||||
| Average ± SD | 35.58 ± 9.18 | 37.27 ± 8.7 | 33.1 ± 9.4 | 0.0258* | |
| MLwHF Total score | |||||
| Median (1st Qu.; 3rd Qu.) | 27 (10.5; 47.0) | 17 (5; 32.5) | 45 (31.5; 55.0) | < 0.0001*** | |
| MLwHF Physical | |||||
| Median (1st Qu.; 3rd Qu.) | 14 (3; 21) | 6 (2; 17.5) | 20 (15; 25) | < 0.0001*** | |
| MLwHF Emotional | |||||
| Median (1st Qu.; 3rd Qu.) | 6 (2; 13) | 3 (0.5; 10.5) | 10.5 (5.75; 15.25) | 0.0001*** | |
| MLwHF General | |||||
| Median (1st Qu.; 3rd Qu.) | 7 (3.0; 14.5) | 4 (1; 8) | 11 (8; 19) | < 0.0001*** | |
| Male | 61(100%) | 38 (62.30%) | 23 (37.70%) | 0.0722 | |
| Schooling | |||||
| Illiterate | 6 (100%) | 3 (50.00%) | 3 (50.00%) | 1.0000 | |
| Education (< 5 years) | 37 (100%) | 24 (64.86%) | 13 (35.14%) | 0.0989 | |
| Education (6-12 years) | 52 (100%) | 31 (59.62%) | 21 (40.38%) | 0.2116 | |
| Education (> 12 years) | 4 (100%) | 1 (25.00%) | 3 (75.00%) | 0.6250 | |
| Married | 64 (100%) | 39 (60.94%) | 25 (39.06%) | 0.1034 | |
| Family support | 82(100%) | 51 (62.20%) | 31 (37.80%) | 0.0352* | |
| Employed | 19 (100%) | 12 (63.16%) | 7 (36.84%) | 0.3593 | |
| Ischemic Etiology | 39(100%) | 21 (53.85%) | 18 (46.15%) | 0.7493 | |
| Absence of atrial fibrillation | 82(100%) | 51 (62.20%) | 31 (37.80%) | 0.0352* | |
| Absence of chronic renal failure | 84(100%) | 52 (61.90%) | 32 (38.10%) | 0.0375* | |
| Absence of diabetes mellitus | 57(100%) | 38 (66.67%) | 19 (33.33%) | 0.0163* | |
| Arterial hypertension | 69(100%) | 39 (56.52%) | 30 (43.48%) | 0.3356 | |
| Absence of previous hospitalization | 63(100%) | 44 (69.84%) | 19 (30.16%) | 0.0022 | |
| Probable anxiety | 15(100%) | 10 (66.67%) | 5 (33.33%) | 0.3018 | |
| Possible anxiety | 35(100%) | 19 (54.29%) | 16 (45.71%) | 0.7359 | |
| Probable depression | 11(100%) | 7 (63.64%) | 4 (36.36%) | 0.5488 | |
| Possible depression | 27(100%) | 15 (55.56%) | 12 (44.44%) | 0.7011 | |
| Current use of betablockers | 96 (100%) | 57 (59.38%) | 39 (40.62%) | 0.0822 | |
| Absence of spironolactone | 38(100%) | 28 (73.68%) | 10 (26.32%) | 0.0051** | |
| Current use of ACE inhibitor/ARB | 94(100%) | 57 (60.64%) | 37 (39.36%) | 0.0495* | |
| Absence Nitrate/Hydralazine | 63(100%) | 43 (68.25%) | 20 (31.75%) | 0.0052** | |
| Absence Furosemide | 25(100%) | 18 (72.00%) | 7 (28.00%) | 0.0433* | |
| Optimized treatment | 87(100%) | 50 (57.47%) | 37 (42.53%) | 0.1980 |
***
p < 0.001;
**
p < 0.01;
*
p < 0.05.
*
P-values were calculated using unpaired t-Student test (for normal continuous variables); Wilcoxon rank sum test (for non-normal continuous variables); and Exact Binomial Test (for categorical variables).
MLwHF: Minnesota Living with Heart Failure; NYHA: New York Heart Association; ACE: Angiotensin-converting enzyme inhibitor; ARB: Angiotensine1 receptor blocker; SD: Standard deviation.